In the fast-evolving world of Cell and Gene Therapy (CGT), digital interoperability isn’t just a technical challenge — it’s a critical enabler for progress. Seamless integration between systems such as LIMS, QMS, analytical devices, and logistics platforms is essential for compliance, data integrity, and operational efficiency.

At Autolomous, we’ve seen firsthand how connecting diverse digital systems can transform manufacturing processes. Our autoloMATE® platform integrates with leading solutions across the CGT ecosystem, allowing our partners to:
👉 Speed up batch record review and release
👉 Eliminate manual data entry and transcription errors
👉 Simplify compliance with version-controlled documents
👉 Unlock real-time insights for data science and process optimization

But interoperability is more than just APIs and standards—it’s about collaboration. By working closely with partners and adopting industry standards, we’re helping to build a common digital approach for the sector. This not only accelerates innovation but also ensures that data flows securely and reliably across the value chain.

As we expand our integration capabilities, we’re excited to collaborate with more organizations to unlock the full potential of CGT. Let’s work together to overcome integration hurdles and drive the industry forward.